Ultragenyx
RARE
$44.24
Share price
0.89%
Change (1 day)
1.31%
Change (1 year)
Categories
Ultragenyx (RARE) - Total assets
Total assets on the balance sheet as of December 2023 : $1.49 B
According to Ultragenyx's latest financial reports the company's total assets are $1.49 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Ultragenyx - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.49 B | -3.52% |
| 2022-12-31 | $1.54 B | 1.51% |
| 2021-12-31 | $1.52 B | -13.48% |
| 2020-12-31 | $1.75 B | 54.96% |
| 2019-12-31 | $1.13 B | 57.8% |
| 2018-12-31 | $0.71 B | 46.62% |
| 2017-12-31 | $0.49 B | -9.23% |
| 2016-12-31 | $0.54 B | -3.39% |
| 2015-12-31 | $0.55 B | 182.66% |
| 2014-12-31 | $0.19 B | 231.89% |
| 2013-12-31 | $59.64 M | -32.46% |
| 2012-12-31 | $88.31 M | 628.14% |
| 2011-12-31 | $12.12 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.22 B | -84.61% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.20 B | -86.20% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.77 B | -47.83% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 358.86% | 🇺🇸 USA |